Barry started his career in '96 at the department of pathology of the academic hospital of Maastricht (azM). For nearly 10 years he worked as a technician on various things, varying from cancer- and atherosclerosis-research to antibody development using phage display. Then he moved to Maastro, were he first worked as a technician and later got his Master’s degree and his PhD. His main focus was investigating the role of an EGFR mutation variant in cancer treatment resistance. Together he worked also nearly 10 years at Maastro before he left for CHILL (Chemelot Innovation and Learning Labs) at Chemelot Geleen. Barry worked at CHILL for nearly 3 years as a researcher/project manager on numerous projects, ranging from testing antimicrobial coatings to synthetic DNA synthesis. After a brief period back at pathology, Barry started in 2020 as a technician at MERLN in the group of Stefan Giselbrecht and will help with developing innovative micro engineered/microfluidic systems to create complex artificial microenvironments for 3D stem cell models.